Immediate thrombocytopenia at time of alemtuzumab infusion for multiple sclerosis – Not always self-limiting, fully reversible or predictable

Siew Mei Yap; Nuala McNicholas; Michael Hutchinson; Christopher McGuigan

doi:10.1177/1352458517719151

Immediate thrombocytopenia at time of alemtuzumab infusion for multiple sclerosis – Not always self-limiting, fully reversible or predictable

Siew Mei Yap, Nuala McNicholas, Michael Hutchinson, Christopher McGuigan

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	552-553
Number of pages	2
Journal	Multiple Sclerosis Journal
Volume	24
Issue number	4
DOIs	https://doi.org/10.1177/1352458517719151
State	Published - 1 Apr 2018
Externally published	Yes

Access to Document

10.1177/1352458517719151

Cite this

@article{e6b1f3e2fd844d639bdde3ba60042d6d,

title = "Immediate thrombocytopenia at time of alemtuzumab infusion for multiple sclerosis – Not always self-limiting, fully reversible or predictable",

author = "Yap, {Siew Mei} and Nuala McNicholas and Michael Hutchinson and Christopher McGuigan",

note = "Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship and/or publication of this article: S.M.Y. has received a Newman Research Fellowship sponsored by Novartis. N.McN. has received a Newman Research Fellowship sponsored by Biogen. M.H. serves on the editorial board of the Multiple Sclerosis Journal and has received support from Dystonia Ireland, the Health Research Board of Ireland and the European Dystonia Foundation. C.McG. has received",

year = "2018",

month = apr,

day = "1",

doi = "10.1177/1352458517719151",

language = "English",

volume = "24",

pages = "552--553",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "4",

}

TY - JOUR

T1 - Immediate thrombocytopenia at time of alemtuzumab infusion for multiple sclerosis – Not always self-limiting, fully reversible or predictable

AU - Yap, Siew Mei

AU - McNicholas, Nuala

AU - Hutchinson, Michael

AU - McGuigan, Christopher

N1 - Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship and/or publication of this article: S.M.Y. has received a Newman Research Fellowship sponsored by Novartis. N.McN. has received a Newman Research Fellowship sponsored by Biogen. M.H. serves on the editorial board of the Multiple Sclerosis Journal and has received support from Dystonia Ireland, the Health Research Board of Ireland and the European Dystonia Foundation. C.McG. has received

PY - 2018/4/1

Y1 - 2018/4/1

UR - http://www.scopus.com/inward/record.url?scp=85041388010&partnerID=8YFLogxK

U2 - 10.1177/1352458517719151

DO - 10.1177/1352458517719151

M3 - Letter

AN - SCOPUS:85041388010

SN - 1352-4585

VL - 24

SP - 552

EP - 553

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - 4

ER -